Evidence map›Paper›PMID 37258935›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2023

Computational Vaccine Design for Common Allergens.

Nandini Ghosh, Gaurab Sircar, Sudipto Saha

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Nandini Ghosh *Department of Microbiology, Vidyasagar University, Midnapore, West Bengal, India.
Gaurab Sircar *Institute of Health Sciences, Presidency University (Newtown Campus), Kolkata, West Bengal, India.
Sudipto SahaDivision of Bioinformatics, Bose Institute, Unified Campus Salt Lake, College More, Kolkata, West Bengal, India. ssaha4@jcbose.ac.in.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this chapter, the steps of designing candidate vaccine molecules for allergen-specific immunotherapy (AIT) using immunoinformatics are described. The most modern approach of AIT deals with carrier-bound B cell epitope and multi-epitope vaccine molecules. The strategy for designing these molecules and the bioinformatics tools and servers used for that are discussed in detail here.

Indexed as

AllergensVaccinesComputational BiologyDesensitization, ImmunologicEpitopes, B-LymphocyteEpitopes, T-LymphocyteAllergensEpitopes, B-LymphocyteEpitopes, T-LymphocyteVaccinesAllergen-specific immunotherapyCarrier-bound B cell epitopeHypoallergenicMulti-epitopeNon-anaphylactic peptideVaccine

Identifiers

PMID37258935

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.